Alzheimer's Aβ1-40 peptide modulates lipid synthesis in neuronal cultures and intact rat fetal brain under normoxic and oxidative stress conditions

Neurochemical Research

Volumn 25, Issue 5, 2000, Pages 653-660

  Koudinova, Natalia V ^a   Koudinov, Alexei R ^a   Yavin, Ephraim ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Alzheimer disease; Neuronal cells; Oxidative stress; Phospholipid metabolism; amyloid peptide

Indexed keywords

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; LIPOGENESIS; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RAT; ANIMAL; AUTORADIOGRAPHY; BIOSYNTHESIS; BRAIN CORTEX; CELL CULTURE; CELL STRAIN; DRUG EFFECT; FETUS; KINETICS; METABOLISM; NERVE CELL; PHYSIOLOGY; PRENATAL DEVELOPMENT;

ACETIC ACID DERIVATIVE; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; CARBON; CHOLESTEROL; PEPTIDE FRAGMENT; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLSERINE; PHOSPHOLIPID;

ACETATES; AMYLOID BETA-PROTEIN; ANIMALS; AUTORADIOGRAPHY; CARBON RADIOISOTOPES; CELLS, CULTURED; CEREBRAL CORTEX; CHOLESTEROL; FETUS; KINETICS; NEURONS; OXIDATIVE STRESS; PC12 CELLS; PEPTIDE FRAGMENTS; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLETHANOLAMINES; PHOSPHATIDYLSERINES; PHOSPHOLIPIDS; RATS;

EID: 0033623895     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007511120099     Document Type: Article

References (41)

1. Greenberg, B. and Murphy, M. 1994. Toward an integrated discovery and development program in Alzheimer's disease: The amyloid hypothesis. Neurobiol. Aging 15:S105-109.
2. Selkoe, D. 1994. Alzheimer's disease: a central role for amyloid. J. Neuropathol. Exp. Neurol. 53:438-447.
3. Shoji, M., Golde, T., Ghiso, J., Cheung, T., Estus, S., Shaffer, L., Cai, X-D., McKay, D., Tintner, R., Frangione, B., and Younkin, S. 1992. Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science 258:126-129.
4. Haass, C., Schlossmacher, M., Hung, A., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B., Lieberburg, I., Koo, E., Schenk, D., Teplow, D., and Selkoe, D. 1992. Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature London 359:322-325.
5. Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee M., Dovey, H., Davis, D., Sinha, S., Schlossmacher, M., Whaley, J., Swindle-Hurst, C., McCormack, R., Wolfert, R., Selkoe, D., Lieberburg, I., and Schenk, D. 1992. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature London 359:325-327.
6. Koudinov, A., Koudinova, N., Kumar, A., Beavis, R., and Ghiso, J. 1996. Biochemical characterization of Alzheimer's soluble amyloid beta protein in human cerebrospinal fluid: association with high density lipoproteins. Biochem. Biophys. Res. Commun. 223:592-597.
7. Koudinov, A. R., Berezov, T. T., Kumar, A., and Koudinova, N. V. 1998. Alzheimer's amyloid β interaction with normal human plasma high density lipoprotein: association with apolipoprotein and lipids. Clin. Chim. Acta 270:75-84.
8. Koudinov, A. R. and Koudinova, N. V. 1997. Soluble amyloid beta protein is secreted by HepG2 cells as an apolipoprotein. Cell Biol. Internat. 25:265-271.
9. Mahley, R., Innerarity, T., Rail, S., and Weisgraber, K. 1984. Plasma lipoproteins: apolipoprotein structure and function. J. Lipid Res. 25:1277-1294.
10. 1-40 and Aβ1-28 inhibit the plasma cholesterol esterification rate. Biochem. Mol. Biol. Inter. 38: 747-752.
11. 1-40 on lipid byosynthesis in HepG2 cells. FEBS Lett. 395:204-206.
12. Ehmann, W. D., Markesbery, W. R., Alauddin, M., Hossain, T. I., and Brubaker, E. H. 1986. Brain trace elements in Alzheimer's disease. Neurotoxicology 7:197-206.
13. Prasad M. R., Lovell M. A., Dhillon H., Markesbery W. 1998. Regional membrane phospholipid alterations in Alzheimer's disease. Neurochem Res 23:81-88.
14. Farooqui, A. A., Wells, K., and Horrocks, L. A. 1995. Breakdown of membrane phospholipids in Alzheimer's disease-involvement of excitatory amino-acid receptors. Mol. Chem. Neuropathol. 25:155-173.
15. Mason, R. P., Shoemaker, W. J., Shajenko, L., Chambers, T. E., and Herbette, L. G. 1992. Evidence for changes in the Alzheimer's disease brain cortical membrane structure mediated by cholesterol. Neurobiology Aging 13:413-418.
16. Nithsch, R. M., Blusztajn, J. K., Pittas, A. G., Slack, B. E., and Wurtman, R. J. 1992. Evidence for a membrane defect in Alzheimer disease brain. Proc. Natl. Acad. Sci. USA. 89:1671-1675.
17. Markesbery, W. R. 1997. Oxidative stress hypothesis in Alzheimer's disease. Free Rad. Biol. Med. 23:134-147.
18. Balasz, L. and Leon, M. 1994. Evidence of an oxidative challenge in the Alzheimer's brain. Neurochem. Res. 19:1131-1137.
19. Bazan, N. G. Jr. 1970. Effects of ischemia and electroconvulsive shock on free fatty acid pool in the brain. Biochim. Biophys. Acta. 218:1-10.
20. Magal, E., Goldin, E., Harel, S., and Yavin, E. 1988. The uteroplacental ischemic rat embryo: A. Lactic acid accumulation and prostaglandin formation in the fetal brain. J. Neurochem. 51: 75-80.
21. Yavin, E. and Marie-Billia, D. 1997. Death in early postmitotic cerebral cortex cells after transient oxygen and glucose deprivation is apoptotic. J. Neurosci. Res. 47:471-478.
22. Hajra, A. and Radin, N. 1978. Lipid extraction of tissues with a low toxicity solvent. Anal. Biochem. 90:420-426.
23. Folch, J., Lees, M., and Sloane-Stanley, G. H. 1957. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226:497-509.
24. Friedman, L. K., Koudinov, A. R. 1999. Unilateral GluR2(B) hippocampal knockdown: a possible novel partial seizure model in young rat. J. Neurosci. 19, 9412-9425.
25. Araki, W., Wurtman, R. J. 1997. Control of membrane phosphatidylcholine biosynthesis by diacylglycerol levels in neuronal cells undergoing neurite outgrowth. Proc Natl Acad Sci U S A, 94:11946-11950.
26. Ulus, I. H, Wurtman, R. J., Mauron, C., Blusztajn, J. K. 1989. Choline increases acetylcholine release and protects against the stimulation-induced decrease in phosphatide levels within membranes of corpus striatum. Brain Res. 484:217-26
27. Wolfe, L. S. 1982. Eicosanoids: Prostaglandins, thromboxane, leukotrienes and other derivatives of carbon- 20 unsaturated fatty acids. J. Neurochem. 38:1-14.
28. Bazan, N. G. 1990. Involvement of arachidonic acid and platelet-activating factor in the response of the nervous system to ischemia and convulsions. In Lipid mediators in ischemic brain damage and experimental epilepsy. New Trends Lipid Mediators Res. 4:241-252.
29. Takai, Y., Kishimoto, A., Inoue, M., and Nishizuka, Y. 1977. Studies on a cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissues. I. Purification and characterization of an active enzyme from bovine cerebellum. J. Biol. Chem. 252:7603-7609.
30. Routtenberg, A. 1986. Synaptic plasticity and protein kinase C. Prog. Brain Res, 69:411-435.
31. Kuperstein, F., Koudinova, N., and Yavin, E. 1998. Regulation of PKC and MAPK-related phosphorylation cascades by β amyloid 1-40 during oxygen deprivation in rat cerebral neurons. Neurosci Lett. 51, S24.
32. Maulik, N., Kagan, V. E., Tyurin, V. A., and Das, D. K. 1998. Redistribution of phosphatidylethanolamine and phosphatidylserine precedes reperfusion-induced apoptosis. Am. J. Physiol. 274:H242-248.
33. Urmoneit, B., Prikulis, I., Wihl, G., Durso, D., Frank, R., Heeren, J., Belsiegel, U., Prior, R. 1997. Cerebrovascular smooth muscle cells internalize Alzheimer amyloid beta protein via a lipoprotein pathway: Implications for cerebral amyloid angiopathy. Lab Investig. 77:157-166.
34. Holtzman, D. M., Bales, K. R., Wu, S., Bhat, P., Parsadanian, M., Pagan, A. M., Chang, L. K., Sun, Y. L., Paul, S. M. 1999. Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease J. Clin. Investig. 103:R15-R21.
35. Glozman, S., and Yavin, E. 1997. Lipid peroxides are generated by fetal rat brain after episodes of global ischemia in utero. Neurochem. Res. 22:201-208.
36. Hophy, M., Harel, S., and Yavin, E. 1996. Prostacyclin accumulates in a rat model of uteroplacental insufficiency: Implications for intrauterine growth retardation. Reprod. Fertil. Dev. 8:895-901.
37. Ames, B. N., Shigenage, M. K., and Hagen, T. M. 1993. Oxidants, antioxidants and the degenerative diseases of aging. Proc Natl Acad Sci USA. 90:7915-7922.
38. Smith, M. A., Hirai, K., Hsiao, K., Pappola, M., and Perry, G. 1998. Amyloid-β deposition in Alzheimer transgenic mice is associated with oxidative stress. J. Neurochem. 70:2212-2215.
39. Gurney, M. E., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y. et al. 1994. Motor neuron degeneration in mice that express a human Cu, Sn, superoxide dismutase mutation. Science 264:1 772-1775.
40. Pettegrew, J. W., Moossy, J., Withers, G., McKeag, D., and Panchalingam, K. 1988. [31P] nuclear magnetic resonance study of the brain in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 47:235-248.
41. Klunk, W. E., Panchalingam, K., McClure, R. J., and Pettegrew, J. W. 1996. Quantitative H-1 and P-31 MRS of PCA extracts of postmortem Alzheimer's disease brain. Neurobiology Aging 17:349-357.